Effects of bile duct ligation and captopril on salt appetite and renin-aldosterone axis in rats

Physiology and Behavior

Volumn 66, Issue 3, 1999, Pages 419-425

  Lane, Jeannine R ^a   Starbuck, Elizabeth M ^a   Johnson, Alan Kim ^b   Fitts, Douglas A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

ACE inhibitors; Aldosterone; Angiotensin; Ascites

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRINKING WATER; RENIN; SODIUM CHLORIDE;

ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; ASCITES; BILE DUCT LIGATION; CHOLESTASIS; COMMON BILE DUCT; CONTROLLED STUDY; FLUID INTAKE; HYPOTENSION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENIN RELEASE; SALT INTAKE; SODIUM APPETITE;

EID: 0032893875     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(98)00295-9     Document Type: Article

References (37)

1. Bomzon A., Weinbroum A., Kamenetz L. Systemic hypotension and pressor responsiveness in cholestasis. A study in conscious. 3-day(bile duct ligated rats. J. Hepatol. 11):1990;70-76.
2. Claria J., Jimenez W., Arroyo V., La Villa G., Lopez C., Asbert M., Castro A., Gaya J., Rivera F., Rodes J. Effect of v1 vasopressin receptor blockade on arterial pressure in conscious rats with cirrhosis and ascites. Gastroenterology. 100:1991;494-501.
3. Daskalopoulos G., Pinzani M., Murray N., Hirschberg R., Zipser R.D. Effects of captopril on renal function in patients with cirrhosis and ascites. J. Hepatol. 4:1987;330-336.
4. Deems R.O., Friedman M.I. Altered preferences for sucrose, sodium chloride, urea and hydrochloric acid solutions in an animal model of cholestatic liver disease. Physiol. Behav. 43:1988;111-114.
5. Deems R.O., Friedman M.I. Sodium chloride preference is altered in a rat model of liver disease. Physiol. Behav. 43:1988;521-525.
6. Elias A.N., Vaziri N.D., Domurat E.S., Pandian M.R., Ansari M.A., Yazdani M. Atrial natriuretic peptide, arginine vasopressin, aldosterone and plasma renin activity in carbon tetrachloride-induced cirrhosis in rats. J. Pharmacol. Exp. Ther. 252:1990;438-441.
7. Epstein A.N. Control of salt intake by steroids and cerebral peptides. Pharmacol. Res. 25:1992;113-124.
8. Evered M.D., Robinson M.M. Increased or decreased thirst caused by inhibition of angiotensin-converting enzyme in the rat. J. Physiol. 348:1984;573-588.
9. Fitts D.A., Lane J.R., Starbuck E.M., Li C.-P. Drinking and blood pressure during sodium depletion or ANG II infusion in chronic cholestatic rats. Am. J. Physiol. 276:1999;R23-R31.
10. Fitts D.A., Masson D.B. Forebrain sites of action for drinking and salt appetite to angiotensin or captopril. Behav. Neurosci. 103:1989;865-872.
11. Fregly M.J., Rowland N.E. Comparison of preference thresholds for NaCl solution in rats of the Sprague-Dawley and Long-Evans strains. Physiol. Behav. 51:1992;915-918.
12. Gentilini P., Romanelli R.G., La Villa G., Maggiore Q., Pesciullesi E., Cappelli G., Casini Raggi V., Foschi M., Marra F., Pinzani M. Effects of low-dose captopril on renal hemodynamics and function in patients with cirrhosis of the liver. Gastroenterology. 104:1993;588-594.
13. Goa K.L., Wagstaff A.J. Losartan potassium. A review of its pharmacology, clinical efficacy and tolerability in the management of hypertension Drugs. 51:1996;820-845.
14. Lane J.R., Louie S., Lee P., Fitts D.A. Induced preference or conditioned aversion for NaCl in rats with chronic bile duct ligation. Physiol. Behav. 63:1998;537-543.
15. Lane J.R., Purhar K.K., Fitts D.A. Drinking in sodium-depleted rats with bile duct, vena cava or portal vein obstruction. Physiol. Behav. 62:1997;1145-1154.
16. Lane J.R., Starbuck E.M., Fitts D.A. Changes in dietary sodium influence drinking in the bile duct ligated rat. Soc. Neurosci. Abstr. 453:1996;22.
17. Lane J.R., Starbuck E.M., Fitts D.A. Ethanol preference, metabolism, blood pressure, and conditioned taste aversion in experimental cholestasis. Pharmacol. Biochem. Behav. 57:1997;755-766.
18. Moller S., Wiinberg N., Hernriksen J.H. Noninvasive 24-hour ambulatory arterial blood pressure monitoring in cirrhosis. Hepatology. 22:1995;88-95.
19. Murray B.M., Paller M.S. Decreased pressor reactivity to angiotensin II in cirrhotic rats. Evidence for a post-receptor defect in angiotensin action Circ. Res. 57:1985;424-431.
20. Nozawa I., Imamura S., Hisamatsu K., Murakami Y. The relationship between orthostatic dysregulation and the orthostatic test in dizzy patients. Eur. Arch. Otorhinolaryngol. 253:1996;268-272.
21. Ohara N., Jaspan J., Chang S.W. Hyperglucagonemia and hyperdynamic circulation in rats with biliary cirrhosis. J. Lab. Clin. Med. 121:1993;142-147.
22. O'Neill P.A., Wait R.B., Kahng K.U. Obstructive jaundice and renal failure in the rat. The role of renal prostaglandins and the renin-angiotensin system Surgery. 108:1990;356-362.
23. Poo J.L., Estanes A., Pedraza-Chaverr'i J., Cruz C., Uribe M. Effects of ursodeoxycholic acid on hemodynamic and renal function abnormalities induced obstructive jaundice in rats. Renal Failure. 17:1995;13-20.
24. Pyykonen M.L., Ylitalo P., Karp M., Nurmi A.K., Tikkanen I. The effect of sodium load on the development of hypertension, plasma renin and kininogen in rats with renal artery constriction. Acta Physiol. Scand. 127:1986;461-466.
25. Robillard J.E., Ramerg E., Sessions C., Consamus B., Van Orden D., Weismann D., Smith F.G. Jr. Role of aldosterone on renal sodium and potassium excretion during fetal life and newborn period. Dev. Pharmacol. Ther. 1:1980;201-216.
26. Saavedra J.M., Fernandez-Pardal J., Chevillard C. Angiotensin-converting enzyme in discrete areas of the rat forebrain and pituitary gland. Brain Res. 245:1982;317-325.
27. Sadowski R.H., Allred E.N., Jabs K. Sodium modeling ameliorates intradialytic and interdialytic symptoms in young hemodialysis patients. J. Am. Soc. Nephrol. 4:1993;1192-1198.
28. Schiffrin E.L., Genest J. Mechanism of captopril-induced drinking. Am. J. Physiol. 242:1982;R136-R140.
29. Schiffrin E.L., Gutkowska J., Genest J. Mechanism of captopril-induced renin release in conscious rats. Proc. Soc. Exp. Biol. Med. 167:1981;327-332.
30. Schrier R.W., Arroyo V., Bernardi M., Epstein M., Henriksen J.H., Rodes J. Peripheral arterial vasodilation hypothesis. A proposal for the initiation of renal sodium and water retention in cirrhosis Hepatology. 8:1988;1151-1157.
31. Schrier R.W., Howard R.L. Pathophysiology of vasopressin in edematous disorders. Folia Endocrinol. Jpn. 65:1989;1311-1327.
32. Stanek B., Renner F., Sedlmayer A., Silberbauer K. Effect of captopril on renin and blood pressure in cirrhosis. Eur. J. Clin. Pharmacol. 33:1987;249-254.
33. Thornton S.N., Sanchez A., Nicolaidis S. An angiotensin-independent, hypotension-induced, sodium appetite in the rat. Physiol. Behav. 57:1995;555-561.
34. Thunhorst R.L., Fitts D.A., Simpson J.B. Separation of effects on salt and water intake by subfornical organ lesions. Am. J. Physiol. 252:1987;R409-R418.
35. Thunhorst R.L., Fitts D.A., Simpson J.B. Angiotensin-converting enzyme in subfornical organ mediates captopril-induced drinking. Behav. Neurosci. 103:1989;1302-1310.
36. Thunhorst R.L., Morris M., Johnson A.K. Endocrine changes associated with a rapidly developing sodium appetite in rats. Am. J. Physiol. 267:1994;R1168-R1173.
37. Villamediana L.M., Garcia-Villalon A.L., Caramelo C., L'opez-Novoa J.M. Effect of dietary sodium intake on the pressor reactivity to angiotensin II in rats with experimental cirrhosis of the liver. Can. J. Physiol. Pharmacol. 67:1989;1506-1511.